Imtiyaz Yousuf

Advancement of metal compounds as therapeutic and diagnostic metallodrugs: Current frontiers and future perspectives

Imtiyaz Yousuf, Masrat Bashir, Farukh Arjmand et al. · Coordination Chemistry Reviews · 2021 · 148 citations

Nanomedicine, Medicinal Chemistry, Future Perspectives +12

Mechanistic insights into a novel chromone-appended Cu(<scp>ii</scp>) anticancer drug entity: in vitro binding profile with DNA/RNA substrates and cytotoxic activity against MCF-7 and HepG2 cancer cells

Imtiyaz Yousuf, Farukh Arjmand, Sartaj Tabassum et al. · Dalton Transactions · 2015 · 98 citations

Synthesis and spectroscopic characterization of diorganotin(<scp>iv</scp>) complexes of N′-(4-hydroxypent-3-en-2-ylidene)isonicotinohydrazide: chemotherapeutic potential validation by in vitro interaction studies with DNA/HSA, DFT, molecular docking and cytotoxic activity

Shipra Yadav, Imtiyaz Yousuf, Mohammad Usman et al. · RSC Advances · 2015 · 76 citations

Molecular Docking, Medicinal Chemistry, Vitro Interaction Studies +14

An overview of advancement of organoruthenium(II) complexes as prospective anticancer agents

Masrat Bashir, Imtiyaz Ahmad Mantoo, Farukh Arjmand et al. · Coordination Chemistry Reviews · 2023 · 69 citations

Inorganic Chemistry, Medicinal Chemistry, Chemoprevention Strategy +8

Synthesis, crystal structure and antiproliferative activity of Cu(II) nalidixic acid–DACH conjugate: Comparative in vitro DNA/RNA binding profile, cleavage activity and molecular docking studies

Farukh Arjmand, Imtiyaz Yousuf, Taïbi Ben Hadda · European Journal of Medicinal Chemistry · 2014 · 62 citations

Crystal Structure, Medicinal Chemistry, Natural Sciences +9